drugset / Trial / NCT07374445
Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery
Phase 4
Completed
100 enrolled
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to compare the weight loss and metabolic benefit in patients remaining obesity at 6 months after metabolic surgery. The main questions it aims to answer are: \[primary hypothesis 1\] Whether liraglutide benefits weight loss when it is initiated early after metabolic surgery. \[primary hypothesis 2\] Whether weight loss and metabolic benefits are greater when linaglutide is initiated in patients who are obese at 6 months after metabolic surgery
Timeline
- Start
- 2023-09-01
- Primary completion
- 2025-06-01
- Completion
- 2025-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liraglutide | Peptide | 3 mg | Other |